Utilisation and Safety of Low Molecular Weight HeparinsProspective Observational Study in Medical Inpatients

被引:0
|
作者
Philippe Cestac
Haleh Bagheri
Maryse Lapeyre-Mestre
Pierre Sié
Atoussa Fouladi
Eric Maupas
Philippe Léger
Bernard Fontan
Patrice Massip
Jean-Louis Montastruc
机构
[1] Faculté de Médecine,Department of Clinical Pharmacology, Centre Midi
[2] Purpan University Hospital,Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament
[3] Purpan University Hospital,Laboratory of Haematology
[4] Purpan University Hospital,Department of Cardiology
[5] Purpan-Casselardit University Hospital,Department of Angiology
[6] Purpan University Hospital,Department of Geriatrics
来源
Drug Safety | 2003年 / 26卷
关键词
Renal Insufficiency; Enoxaparin; Deep Venous Thrombosis; Oral Anticoagulant; Thrombocytosis;
D O I
暂无
中图分类号
学科分类号
摘要
Aims: Low molecular weight heparins (LMWHs) are widely used as curative or preventive treatments of thromboembolic diseases. The aim of our study was to: (i) investigate the pattern of prescription of LMWHs in different departments of French teaching hospitals; and (ii) estimate the incidence of adverse drug reactions (ADRs) induced by LMWHs and associated risk factors for the occurrence of bleeding events.
引用
收藏
页码:197 / 207
页数:10
相关论文
共 50 条
  • [1] Utilisation and safety of low molecular weight heparins -: Prospective observational study in medical inpatients
    Cestac, P
    Bagheri, H
    Lapeyre-Mestre, M
    Sié, P
    Fouladi, A
    Maupas, E
    Léger, P
    Fontan, B
    Massip, P
    Montastruc, JL
    DRUG SAFETY, 2003, 26 (03) : 197 - 207
  • [2] Utilisation and safety of bemiparin, a low-molecular-weight heparin, in medical patients -: A prospective, uncontrolled cohort study
    Miras-Parra, F
    Navascués -Martínez, E
    Gómez-Outes, A
    Martínez-González, J
    Rocha, E
    CLINICAL DRUG INVESTIGATION, 2005, 25 (07) : 463 - 472
  • [3] Utilisation and Safety of Bemiparin, a Low-Molecular-Weight Heparin, in Medical PatientsA Prospective, Uncontrolled Cohort Study
    Francisco Miras-Parra
    Emilia Navascués-Martínez
    Antonio Gómez-Outes
    Javier Martínez-González
    Eduardo Rocha
    Clinical Drug Investigation, 2005, 25 : 463 - 472
  • [4] Activity level of hospital medical inpatients: An observational study
    Kuys, Suzanne S.
    Dolecka, Urszula E.
    Guard, Amanda
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2012, 55 (02) : 417 - 421
  • [5] Physical examination in the care of medical inpatients: an observational study
    Reilly, BM
    LANCET, 2003, 362 (9390): : 1100 - 1105
  • [6] Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital
    Huimin Xu
    Hongwen Cai
    Zhongshu Qian
    Geng Xu
    Xiaofeng Yan
    Haibin Dai
    BMC Cardiovascular Disorders, 12
  • [7] Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital
    Xu, Huimin
    Cai, Hongwen
    Qian, Zhongshu
    Xu, Geng
    Yan, Xiaofeng
    Dai, Haibin
    BMC CARDIOVASCULAR DISORDERS, 2012, 12
  • [8] Outcomes and costs of thromboprophylaxis with low-molecular weight heparin in acutely-ill medical inpatients
    Thompson, D
    McGarry, L
    VALUE IN HEALTH, 2002, 5 (06) : 481 - 481
  • [9] Subcutaneous low-molecular weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients
    Harenberg, J
    Roebruck, P
    Heene, DL
    HAEMOSTASIS, 1996, 26 (03) : 127 - 139
  • [10] Enoxaparin utilization evaluation: An observational prospective study in medical inpatients
    Fahimi, Fanak
    Baniasadi, Shadi
    Behzadnia, Neda
    Varahram, Fatemeh
    Tabatabaie, Leila Ghazi
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2008, 7 (01): : 77 - 82